Should FDA Approval of aura6000 Sleep Apnea Therapy Require Action From LivaNova (LIVN) Investors? [Yahoo! Finance]
LivaNova PLC - Ordinary Shares (LIVN)
Last livanova plc - ordinary shares earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
livanova.com
Company Research
Source: Yahoo! Finance
therapy for adults with moderate to severe obstructive sleep apnea who cannot use or benefit from first-line options like positive airway pressure. Backed by the rigorously designed OSPREY randomized controlled trial and plans for an MRI-compatible, rechargeable next-generation device, this approval positions LivaNova to expand its neuromodulation footprint into the obstructive sleep apnea market with a differentiated technology platform. We'll now examine how FDA approval of the aura6000 System, supported by OSPREY trial outcomes, may reshape LivaNova's broader investment narrative. Uncover the next big thing with 29 elite penny stocks that balance risk and reward. LivaNova Investment Narrative Recap To own LivaNova, you need to believe it can turn its neuromodulation and cardiopulmonary franchises into a sustainably profitable, higher-margin medtech portfolio despite current losses. FDA approval of aura6000 adds a new OSA growth leg, but in the near term the key catalyst r
Show less
Read more
Impact Snapshot
Event Time:
LIVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIVN alerts
High impacting LivaNova PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LIVN
News
- LivaNova to Announce First-Quarter 2026 ResultsBusiness Wire
- LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep ApneaBusiness Wire
- All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- A Look At LivaNova (LIVN) Valuation After Earnings Show Growth Guidance And A Swing To Net Loss [Yahoo! Finance]Yahoo! Finance
- LivaNova (LIVN) had its price target raised by Barclays PLC from $67.00 to $73.00. They now have an "equal weight" rating on the stock.MarketBeat
LIVN
Earnings
- 2/25/26 - Beat
LIVN
Sec Filings
- 3/13/26 - Form 4
- 2/25/26 - Form IRANNOTICE
- 2/25/26 - Form 10-K
- LIVN's page on the SEC website